Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
30.05.AstraZeneca receives CHMP recommendation for Imfinzi regimen in bladder cancer
30.05.Sanofi and Stagecoach Performing Arts partner to highlight impact of autoimmune type 1 diabetes
30.05.UKDRI researchers to evaluate new blood test for neurodegenerative disease diagnosis
30.05.In an era of deep uncertainty, life sciences companies require more than agile communications
30.05.Can we create a world where health is sustainable?
29.05.Biogen and City Therapeutics to develop RNAi therapies in deal worth over $1bn
29.05.Sanofi gains access to Alzheimer's candidate through $470m Vigil acquisition
29.05.The future of customer engagement in biopharma
28.05.J&J's Darzalex Faspro recommended by FDA panel of experts for smouldering multiple myeloma
28.05.Merck shares promising phase 3 results for Keytruda in ovarian cancer
28.05.Improving engagement with clinical trials: time to apply behavioural science
27.05.Bristol Myers Squibb's perioperative Opdivo regimen granted EC approval in NSCLC
27.05.Boehringer's nerandomilast shows lung function benefit in phase 3 IPF and PPF trials
27.05.Exploring AI in pharma: how can we achieve lift-off?
23.05.BioNTech announces £1bn UK investment to boost regional R&D presence
23.05.Researchers uncover promising treatment approach for inherited breast cancer
23.05.Clinical trials - overcoming the barriers to improved enrolment and retention
22.05.Regeneron to acquire human genetics company 23andMe for $256m
22.05.AstraZeneca shares late-stage results for Airsupra in mild asthma patients
21.05.Pfizer gains rights to 3SBio's investigational bispecific antibody in deal worth over $6bn
21.05.Merck's Welireg granted FDA approval to treat rare tumour types PPGL
21.05.VML appoints Philippe Huot-Louradour as director of VML Health France
20.05.J&J's Tremfya approved by MHRA to treat Crohn's disease and ulcerative colitis
20.05.FDA approves Fujirebio's Lumipulse as first Alzheimer's disease blood test
20.05.Alnylam shares phase 3 results for Amvuttra in rare heart disease ATTR-CM